Higher dividends and lower fees from Jupiter Green – The annual report for Jupiter Green Investment Trust PLC (JGC) has been released for the year to 31 March 2018. Performance Every year, shareholders of Jupiter Green can subscribe for one new ordinary shares for every ten shares they already own. As a result, the performance of the […]
Funding Circle SME Income cuts dividend forecast – Funding Circle SME Income Fund’s board has announced that it “has noted a material increase in the cost of hedging the company’s US Dollar-denominated assets back into sterling“. It blames “divergent monetary policy and economic prospects in the US and UK, which has seen a significant widening […]
Tritax Big Box forward funds Darlington facility – Tritax Big Box REIT has exchanged contracts for the forward funded development of a new logistics fulfilment centre at Link 66, Darlington, pre-let to a “financially robust world leading retailer”. Completion is expected in early July 2018 when the land will be acquired and the development will […]
JPMorgan Japan Smaller Companies introduces new dividend policy In its final report for the year ending 31st March 2018, the board of JPMorgan Japan Smaller Companies (JPS) announced that, as a move to reduce the company’s discount to NAV, rather than buy back shares and to make the company more attractive to savers, it proposes to […]
Miton Global Opportunities reports upbeat results as liquidity opportunity looms – Miton Global Opportunities has reported a total return on net assets of 11.1% for the year ended 30 April 2018. the return to shareholders was a bit better at 12.7%, reflecting a narrowing of its discount to 1.2%. The fund compares itself to a […]
HBM gains on IPO of investee Aptinyx HBM Healthcare (HBMN) should be able to see a ~CHF15m gain in NAV, following the IPO of investee company Aptinyx on Nasdaq earlier this week and the 40% rise in its stock price since. Aptinyx (Nasdaq: APTX) raised gross proceeds of $118m from the sale of 7.4m shares at […]
Key regulatory updates biotech specialist trust investees Two stocks that core holdings for biotech specialist trusts have reported important regulatory updates in the past week, with several other companies approaching key events, as detailed below. Array BioPharma (Nasdaq: ARRY), a top ten holding for International Biotechnology Trust (IBT), received FDA approval for Braftovi in combination with Mektovi […]
Aberdeen New Dawn overcomes heightened volatility – Aberdeen New Dawn (ABD) aims to provide shareholders with a high level of capital growth through equity investment in the Asia Pacific countries ex Japan. Performance In its annual financial report for the year ended 30 April 2018, the company reported that its NAV rose by 12.9% during a challenging […]
Ediston frees up floor space at St Philips Point – Ediston Property Investment Company has restructured its lease terms with Weightmans LLP (‘Weightmans’) at St Philips Point, Birmingham. At the moment, Weightmans occupy 37,395 sq. ft. across three floors, on three leases which expire in July 2019. The current annual rent is GBP606,452. Ediston has signed […]
Schroder UK Growth delivers last report before manager change – the board of Schroder UK Growth (SDU) announced in April that the manager would move from Schroder Unit Trusts Limited as its alternative investment fund manager (AIFM) and has appoint Baillie Gifford & Co Limited as the company’s new manager, company secretary and administrator. Click here to […]
Sequoia hit by sterling strength – For the financial year ended 31 March 2018, Sequoia Economic Infrastructure has reported a fall in its NAV from 102.72p to 101.32p. Over the same period, it paid dividends of 6p per share, resulting in a total return of 4.1% over the year. Over the year, the appreciation of sterling against […]
Invesco Asia misses out on Alibaba rise – Invesco Asia has reported a return of 14.5% on NAV for the year ended 31 March 2018. This is a bit behind the 16.8% return on its benchmark, the MSCI All Countries Asia ex Japan index. Shareholders were also impacted by a widening of Invesco Asia’s discount, their return […]
Securities Trust of Scotland; another company lowering its fees – The board of Securities Trust of Scotland (STS) and Martin Currie, the investment manager, have agreed a lower management fee. New fee structure The new fee structure, which has been in place since 1st April 2018, was outlined in the company’s annual financial results for the […]
Monks; strong performance with lower fees – the Annual Financial Report of The Monks Investment Trust PLC (MNKS) for the year ended 30 April 2018 has been published. Performance The NAV total return of MKNS, with borrowings calculated at fair value, was 15.8% and the share price total return was 20.4%. Over the same period the total […]
Investment Trust Insider on BlackRock Emerging Europe James Carthew: BlackRock trust could have avoided upset There have been some fun and games in the investment trust sector recently, what with the ongoing dispute between Invesco Perpetual Enhanced Income (IPE) and its former manager, the proposed merger of Dunedin Smaller Companies (DNDL) and Standard Life UK […]
IP Group investee Carisma Therapeutics closes $53m fundraising Carisma Therapeutics, a US-based investee company for LSE-listed IP Group (IPO), has closed a $53m series A fundraising. The financing was led by AbbVie Ventures, the corporate venture arm of the US pharmaceutical giant, and HealthCap, an EU VC investor, and included the existing seed investors, IP Group, Penn […]
Invesco team reappointed to Invesco Enhanced – The board of Invesco Perpetual Enhanced Income Limited (“IPE”) has reached a resolution of IPE’s management arrangements. Following discussions between the board and Invesco Fund Managers Limited (Invesco), and following a process to consult with major shareholders, the board has decided to reappoint Invesco as the manager of IPE. Paul […]
Vietnam Holding reappoints old manager- Vietnam Holding (VNH) was in the news a lot in May. It first announced on 16th May, that it was changing its investment agreement with its existing investment manager and wanted to increase its size by acquiring the assets of another Vietnamese listed equity fund (click here to read more on that story). […]
Highcroft invests in Birmingham health and fitness club – Highcroft Investments (HCFT) has exchanged on the purchase of the freehold interest of a health and fitness club investment in Birmingham from BAE Systems Pension Funds Trustees Limited. The property comprises a purpose built health and fitness club, with swimming pool, of approximately 37,500 sq ft, on […]
Triple Point adds to its social housing portfolio – Triple Point Social Housing REIT (SOHO) manages a portfolio of social housing assets in the UK, with a particular focus on supported housing. Triple Point adds to its social housing portfolio The group has exchanged contracts on two supported housing properties completed the acquisition of three supported housing properties acquired land and entered […]
Picton completes the disposal of two office assets – closed-ended property investment company, Picton Property Income (PCTN) has completed the sale of two offices, both in separate transactions with local authorities. Picton has sold 800 Pavilion Drive, Northampton, a detached office building, let to Ricoh UK on a lease expiring in June 2023. The sale price of £7.95 […]
IBT favourite Array updates trial results ahead of key FDA decision Array Biopharma (ARRY), a top ten holding for LSE-listed International Biotechnology Trust (IBT), has reported positive results from a safety lead-in phase of a pivotal trial of a triplet therapy comprising two of its drugs – binimetinib and encorafenib – with Merck KGaA’s Erbutix in BRAF mutant […]
Arix, Syncona and WPCT bank gains after Autolus “pops” on Nasdaq IPO Arix Bioscience (ARIX), Syncona (SYNC) and Woodford Patient Capital Trust (WPCT) should be able to record some sizeable NAV gains this month, as previously highlighted in earlier Quoteddata.com articles, on the back of a revaluation to market value of their respective holdings in the common portfolio […]
LXi REIT swaps two care homes for a Stobart industrial facility – After an unsolicited approach, LXi has sold two care homes in Leicestershire let to Prime Life to a UK pension fund for £19.0 million. They say that this: reflects a low exit yield of 5.25%, which compares favourably to the acquisition yield of 6.50% […]
Henderson Far East to shift to UK – Henderson Far East Income has published proposals to migrate to UK tax residence and apply for UK investment trust status. The fund currently earns investment income from a diversified portfolio of investments with exposure to the Asia Pacific region, much of which is subject to overseas withholding […]
NextEnergy Solar adds another ten plants – NextEnergy Solar Fund has announced the signing and completion of a share purchase agreement for the acquisition of ten operating solar plants with a total installed capacity of 46.6 MWp. The plants were acquired from a single counterparty, from which the company has previously acquired five solar power […]
John Laing Environmental commits to Vulcan plant expansion – John Laing Environmental Assets Group has announced a further investment in the Vulcan Renewables anaerobic digestion (AD) plant. The investment consists of provision of funding of c.£8.5m to significantly expand the AD plant’s biomethane generating capacity. Vulcan Renewables was acquired in August 2017. The plant is located […]
Hansa Trust has a better year – Hansa Trust has reported its results for the year ended 31 March 2018. Over this period, while inflation was 2.5% and the return on the MSCI All Countries World Index was 2.6%, it delivered a return on NAV of 6.3% and returns to shareholders of 16.5% on its ordinary […]
US biotech IPO market faces key test after record five pricings The currently buoyant US market for biotech new issues faces a key test, after a record five companies priced Nasdaq offerings in a single day. The success of those listings in the immediate after-market is likely to be important gauge of the overall health […]
Reconstruction Capital II returned €17.4m to its shareholders– In its annual report for the year ending 31 December 2017, Reconstruction Capital II (RC2) reported that its NAV decreased by 31.8% from €0.3670 per share to €0.2504 per share. This was because it returned €17.4m to Shareholders over the year. The majority of this was the proceeds of the sale of Albalact S.A. […]
